Peter Fernandes

Companies

• Bellerophon Therapeutics (United States)Chief Regulatory Officer May 20, 2015 to Jun 9, 2023¹
• Bellerophon Therapeutics (United States)Chief executive officer Feb 14, 2023 to Feb 14, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• BTBellerophon Therapeutics (United States)22,515 shares³Dec 9, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Dec 9, 2022Shares withheld for tax 9,985 shares at $0.93 of Bellerophon Therapeutics (United States)³
• Dec 9, 2022Exercised options 32,500 shares of Bellerophon Therapeutics (United States)³